多毛症の市場規模、シェア、動向分析レポート:治療タイプ別(投薬、処置)、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年Hirsutism Market Size, Share & Trends Analysis Report By Treatment Type (Medications, Procedures), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 多毛症市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の多毛症市場規模は2030年までに50億米ドルに達すると予測され、2024年から2030年までの年平均成長率は7.2%で拡大すると予測... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー多毛症市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界の多毛症市場規模は2030年までに50億米ドルに達すると予測され、2024年から2030年までの年平均成長率は7.2%で拡大すると予測されています。多毛症市場は、現在蔓延しているCOVID-19の大流行によってマイナスの影響を受けている。2021年9月のNCBIの記事によると、エールらの研究は、多嚢胞性卵巣症候群(PCOS)を含む高アンドロゲン女性、多毛症、COVID-19の関連を調べた。 この研究では、高アンドロゲン症のCOVID-19陽性女性の入院率は4.5%から8%であり、これらの疾患のない女性では11.4%から11.7%であったのに比べ、死亡率の有意な上昇は認められなかった。さらに、これらの女性におけるCOVID-19感染や入院の発生率は、スピロノラクトン、エストラジオール、メトホルミンなどの治療薬の使用と有意な関連はないようであった。 レーザー脱毛の需要は、美容施術の増加や美容意識の高まりにより、特に市場において増加している。レーザー脱毛は、ムダ毛とそれに関連する美容的・心身的懸念に対する最も一般的な解決策である。国際美容整形学会によると、2022年、脱毛施術は美容治療の主要な部分を占め、女性・男性合わせて180万件以上の施術が行われた。この脱毛施術の増加は、ムダ毛に対する効果的かつ恒久的な解決策への需要を浮き彫りにしている。 多毛症市場レポートハイライト - 2023年の治療タイプ別シェアは薬が56.8%以上を占め、主流を占める。 - 手技分野は予測期間中に最も速いCAGRで成長する見込み - 上唇セグメントは2023年に25.6%の最大市場シェアを占めた。顎セグメントは予測期間中に大きく成長すると予測される。顎の外側の角と上唇の顔の毛が薄い女性は一般的であり、多毛症の有病率の増加に寄与している。 - 北米は、多毛症の有病率の増加、購買力平価の高さ、質の高い医療に対する政府の支援、償還の利用可能性などの要因により、多毛症市場を支配している。 - 2022年10月、非腫瘍性疾患および腫瘍性疾患に対する非常に効果的で、低侵襲、非侵襲、かつ低コストな治療を専門とする医療機器メーカーであるSensus healthcare社は、波長をブレンドした可動式シルクby sensus脱毛システムを発表した。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Treatment type 1.2.2. Application 1.2.3. End-use 1.2.4. Regional scope 1.2.5. Estimates and forecasts timeline 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.4.5. Details of primary research 1.4.5.1. Data for primary interviews in North America 1.4.5.2. Data for primary interviews in Europe 1.4.5.3. Data for primary interviews in Asia Pacific 1.4.5.4. Data for primary interviews in Latin America 1.4.5.5. Data for Primary interviews in MEA 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Approach 1: Commodity flow approach 1.7.3. Volume price analysis (Model 2) 1.7.4. Approach 2: Volume price analysis 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Treatment Type 2.2.2. Application 2.2.3. End-use 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Hirsutism Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of hirsutism among women 3.2.1.2. Cosmetic and psychology problems associated with unwanted hair 3.2.1.3. Rising prevalence of polycystic ovary syndrome 3.2.2. Market restraint analysis 3.2.2.1. High cost of the laser hair removal procedures 3.3. Hirsutism Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape Chapter 4. Hirsutism Market: Treatment Type Estimates & Trend Analysis 4.1. Treatment type Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Hirsutism Market by Treatment Type Outlook 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.4.1. Medications 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2. Procedures 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.3. Others 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 5. Hirsutism Market: Application Estimates & Trend Analysis 5.1. Application Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Hirsutism Market by Application Outlook 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.4.1. Upper Lip 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.2. Chin 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.3. Chest 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.4. Arms 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5. Others 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 6. Hirsutism Market: End-use Estimates & Trend Analysis 6.1. End-use Market Share, 2023 & 2030 6.2. Segment Dashboard 6.3. Global Hirsutism Market by End-use Outlook 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.4.1. Hospitals 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million) 6.4.2. Dermatology Clinics & Aesthetic Centers 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 6.4.3. Others 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 7. Hirsutism Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 7.5. North America 7.5.1. U.S. 7.5.1.1. Key country dynamics 7.5.1.2. Regulatory framework/ reimbursement structure 7.5.1.3. Competitive scenario 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) 7.5.2. Canada 7.5.2.1. Key country dynamics 7.5.2.2. Regulatory framework/ reimbursement structure 7.5.2.3. Competitive scenario 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Regulatory framework/ reimbursement structure 7.6.1.3. Competitive scenario 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Regulatory framework/ reimbursement structure 7.6.2.3. Competitive scenario 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Regulatory framework/ reimbursement structure 7.6.3.3. Competitive scenario 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Regulatory framework/ reimbursement structure 7.6.4.3. Competitive scenario 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Regulatory framework/ reimbursement structure 7.6.5.3. Competitive scenario 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) 7.6.6. Norway 7.6.6.1. Key country dynamics 7.6.6.2. Regulatory framework/ reimbursement structure 7.6.6.3. Competitive scenario 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Regulatory framework/ reimbursement structure 7.6.7.3. Competitive scenario 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) 7.6.8. Denmark 7.6.8.1. Key country dynamics 7.6.8.2. Regulatory framework/ reimbursement structure 7.6.8.3. Competitive scenario 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Regulatory framework/ reimbursement structure 7.7.1.3. Competitive scenario 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) 7.7.2. China 7.7.2.1. Key country dynamics 7.7.2.2. Regulatory framework/ reimbursement structure 7.7.2.3. Competitive scenario 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) 7.7.3. India 7.7.3.1. Key country dynamics 7.7.3.2. Regulatory framework/ reimbursement structure 7.7.3.3. Competitive scenario 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) 7.7.4. Australia 7.7.4.1. Key country dynamics 7.7.4.2. Regulatory framework/ reimbursement structure 7.7.4.3. Competitive scenario 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) 7.7.5. South Korea 7.7.5.1. Key country dynamics 7.7.5.2. Regulatory framework/ reimbursement structure 7.7.5.3. Competitive scenario 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Regulatory framework/ reimbursement structure 7.7.6.3. Competitive scenario 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Regulatory framework/ reimbursement structure 7.8.1.3. Competitive scenario 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Regulatory framework/ reimbursement structure 7.8.2.3. Competitive scenario 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Regulatory framework/ reimbursement structure 7.8.3.3. Competitive scenario 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Regulatory framework/ reimbursement structure 7.9.1.3. Competitive scenario 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Regulatory framework/ reimbursement structure 7.9.2.3. Competitive scenario 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Regulatory framework/ reimbursement structure 7.9.3.3. Competitive scenario 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Regulatory framework/ reimbursement structure 7.9.4.3. Competitive scenario 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2023 8.3.4. Ajanta Pharma 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Alma Lasers Ltd. 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Alpaya Dermaceuticals 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. Cynosure Inc. 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Lumenis Inc. 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Nisim Inc. 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Sciton International 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Koninklijke Philips N.V 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. Merck & Co., Inc. 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Pfizer Inc. 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Cutera Inc. 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives 8.3.15. El.En. S.p.A. 8.3.15.1. Company overview 8.3.15.2. Financial performance 8.3.15.3. Product benchmarking 8.3.15.4. Strategic initiatives
SummaryHirsutism Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Treatment type 1.2.2. Application 1.2.3. End-use 1.2.4. Regional scope 1.2.5. Estimates and forecasts timeline 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.4.5. Details of primary research 1.4.5.1. Data for primary interviews in North America 1.4.5.2. Data for primary interviews in Europe 1.4.5.3. Data for primary interviews in Asia Pacific 1.4.5.4. Data for primary interviews in Latin America 1.4.5.5. Data for Primary interviews in MEA 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Approach 1: Commodity flow approach 1.7.3. Volume price analysis (Model 2) 1.7.4. Approach 2: Volume price analysis 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Treatment Type 2.2.2. Application 2.2.3. End-use 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Hirsutism Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of hirsutism among women 3.2.1.2. Cosmetic and psychology problems associated with unwanted hair 3.2.1.3. Rising prevalence of polycystic ovary syndrome 3.2.2. Market restraint analysis 3.2.2.1. High cost of the laser hair removal procedures 3.3. Hirsutism Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape Chapter 4. Hirsutism Market: Treatment Type Estimates & Trend Analysis 4.1. Treatment type Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Hirsutism Market by Treatment Type Outlook 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.4.1. Medications 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2. Procedures 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.3. Others 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 5. Hirsutism Market: Application Estimates & Trend Analysis 5.1. Application Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Hirsutism Market by Application Outlook 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.4.1. Upper Lip 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.2. Chin 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.3. Chest 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.4. Arms 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5. Others 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 6. Hirsutism Market: End-use Estimates & Trend Analysis 6.1. End-use Market Share, 2023 & 2030 6.2. Segment Dashboard 6.3. Global Hirsutism Market by End-use Outlook 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.4.1. Hospitals 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million) 6.4.2. Dermatology Clinics & Aesthetic Centers 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) 6.4.3. Others 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 7. Hirsutism Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 7.5. North America 7.5.1. U.S. 7.5.1.1. Key country dynamics 7.5.1.2. Regulatory framework/ reimbursement structure 7.5.1.3. Competitive scenario 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) 7.5.2. Canada 7.5.2.1. Key country dynamics 7.5.2.2. Regulatory framework/ reimbursement structure 7.5.2.3. Competitive scenario 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Regulatory framework/ reimbursement structure 7.6.1.3. Competitive scenario 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Regulatory framework/ reimbursement structure 7.6.2.3. Competitive scenario 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Regulatory framework/ reimbursement structure 7.6.3.3. Competitive scenario 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Regulatory framework/ reimbursement structure 7.6.4.3. Competitive scenario 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Regulatory framework/ reimbursement structure 7.6.5.3. Competitive scenario 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) 7.6.6. Norway 7.6.6.1. Key country dynamics 7.6.6.2. Regulatory framework/ reimbursement structure 7.6.6.3. Competitive scenario 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Regulatory framework/ reimbursement structure 7.6.7.3. Competitive scenario 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) 7.6.8. Denmark 7.6.8.1. Key country dynamics 7.6.8.2. Regulatory framework/ reimbursement structure 7.6.8.3. Competitive scenario 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Regulatory framework/ reimbursement structure 7.7.1.3. Competitive scenario 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) 7.7.2. China 7.7.2.1. Key country dynamics 7.7.2.2. Regulatory framework/ reimbursement structure 7.7.2.3. Competitive scenario 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) 7.7.3. India 7.7.3.1. Key country dynamics 7.7.3.2. Regulatory framework/ reimbursement structure 7.7.3.3. Competitive scenario 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) 7.7.4. Australia 7.7.4.1. Key country dynamics 7.7.4.2. Regulatory framework/ reimbursement structure 7.7.4.3. Competitive scenario 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) 7.7.5. South Korea 7.7.5.1. Key country dynamics 7.7.5.2. Regulatory framework/ reimbursement structure 7.7.5.3. Competitive scenario 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Regulatory framework/ reimbursement structure 7.7.6.3. Competitive scenario 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Regulatory framework/ reimbursement structure 7.8.1.3. Competitive scenario 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Regulatory framework/ reimbursement structure 7.8.2.3. Competitive scenario 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Regulatory framework/ reimbursement structure 7.8.3.3. Competitive scenario 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Regulatory framework/ reimbursement structure 7.9.1.3. Competitive scenario 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Regulatory framework/ reimbursement structure 7.9.2.3. Competitive scenario 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Regulatory framework/ reimbursement structure 7.9.3.3. Competitive scenario 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Regulatory framework/ reimbursement structure 7.9.4.3. Competitive scenario 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2023 8.3.4. Ajanta Pharma 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Alma Lasers Ltd. 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Alpaya Dermaceuticals 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. Cynosure Inc. 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Lumenis Inc. 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Nisim Inc. 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Sciton International 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Koninklijke Philips N.V 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. Merck & Co., Inc. 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Pfizer Inc. 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Cutera Inc. 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives 8.3.15. El.En. S.p.A. 8.3.15.1. Company overview 8.3.15.2. Financial performance 8.3.15.3. Product benchmarking 8.3.15.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |